BioWorld

June 16, 2005

Chiron Lowers Estimates For Flu Vaccine Production

Chiron Inc. has reduced its estimated production range for Fluvirin, citing delays in start-up procedures, as the company gears up for full vaccine production for the 2005-2006 flu season. (BioWorld Today) Read More

NeurogesX Starts Phase III Study Of NGX-4010 In Pain

Despite Detractors, Crawford Nomination Moving Forward

Research Heritage In Flanders Bringing Commercial Success

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 26, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 23, 2026.

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...